This consequently decreases HDL-cholesterol levels and raises apoB and LDL-cholesterol; in particular the small, dense LDL subclass, a particularly atherogenic lipoprotein, which is considered a key risk factor for ASCVD(36). Here, APOB is linked to atherosclerosis.